Premium
Dynamics of conditional survival and risk factors in androgen deprivation therapy for prostate cancer using a multi‐institutional Japan‐wide database
Author(s) -
Chikamatsu Sotaro,
Shiota Masaki,
Onozawa Mizuki,
Hinotsu Shiro,
Kitagawa Yasuhide,
Sakamoto Shinichi,
Kawai Taketo,
Eto Masatoshi,
Kume Haruki,
Akaza Hideyuki
Publication year - 2021
Publication title -
international journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.172
H-Index - 67
eISSN - 1442-2042
pISSN - 0919-8172
DOI - 10.1111/iju.14605
Subject(s) - medicine , prostate cancer , androgen deprivation therapy , oncology , cancer , proportional hazards model , survival rate , prostate , survival analysis , database , computer science
Objectives The objectives of this study were to analyze the conditional survival and prognostic factors in androgen deprivation therapy for prostate cancer using the Japan Study Group of Prostate Cancer database. Methods Data on patients treated with primary androgen deprivation therapy between 2001 and 2003 from a nationwide database of the Japan Study Group of Prostate Cancer were used. The conditional 5‐year progression‐free rate, cancer‐specific survival and overall survival, as well as the conditional mortality owing to prostate cancer and other causes were calculated as per subgroups. Prognostic factors for progression‐free rate, cancer‐specific survival and overall survival at each time after androgen deprivation therapy initiation were calculated using the Cox proportional hazards model. Results The conditional 5‐year progression‐free rate and cancer‐specific survival, but not overall survival, gradually increased with time. The prognostic impact of stage IV characteristics (T4, N1 and M1) changed over time; however, the prognostic impact of the Gleason score remained unchanged. In the subgroup analysis, prostate‐specific mortality risk reduced over time in patients with stage IV prostate cancer, whereas non‐prostate cancer mortality increased over time in elderly patients. Conclusions Information regarding conditional survival and mortality obtained in this study would provide a benchmark for physicians and cancer survivors.